A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
NCT01305824
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
151
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Kidney Disease
Interventions
DRUG:
PRT-201
DRUG:
Placebo
DRUG:
PRT-201
Sponsor
Proteon Therapeutics